Influence of Residual Tumor on Outcome in Ovarian Cancer Patients With FIGO Stage IV Disease: An Exploratory Analysis of the AGO-OVAR (Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group) - Wimberger, Pauline; Wehling, Michael; Lehmann, Nils; Kimmig, Rainer; Schmalfeldt, Barbara; Burges, Alexander; Harter, Philipp; Pfisterer, Jacobus; du Bois, Andreas (Annals of surgical oncology, 2010)
Keywords: Antineoplastic Combined Chemotherapy Protocols - therapeutic use; Cisplatin - administration & dosage; Disease-Free Survival; Female; Gynecologic Oncology; Humans; Infusions, Intravenous; Medicine; Medicine & Public Health; Multicenter Studies as Topic; Multivariate Analysis; Neoplasm Staging; Neoplasm, Residual - pathology; Neoplasm, Residual - therapy; Oncology; Ovarian cancer; Ovarian Neoplasms - drug therapy; Ovarian Neoplasms - mortality; Ovarian Neoplasms - pathology; Ovarian Neoplasms - surgery; Ovarian Neoplasms - therapy; Paclitaxel - administration & dosage; Proportional Hazards Models; Randomized Controlled Trials as Topic; Research Design; Surgery; Surgical Oncology; Survival Analysis; Treatment Outcome; Complete Resection; Epithelial Ovarian Cancer; Overall Survival; Residual Tumor; Median Overall Survival